The study reveals that four units of ZapA protein form an asymmetric ladder-like structure with FtsZ protofilaments, impacting the alignment of the Z-ring. The interaction between ZapA and FtsZ is dynamic, with cooperative binding and structural alterations, enabling the maintenance of FtsZ mobility.
The team built a high-resolution 3D structure of the Powassan virus, shedding light on its transmission and potential therapeutics. The findings could inform future treatments and preventions for this emerging tick-borne disease.
Scientists from the University of Bath have identified two new families of chemical compounds that inhibit alpha-methylacyl-CoA racemase (MCR) in Mycobacterium tuberculosis, a key enzyme for TB survival. This breakthrough could lead to new treatments for TB and potentially other diseases like prostate cancer.
Researchers at King's College London used cryo-electron microscopy to study the flagellum in unprecedented detail, revealing its architecture and identifying potential drug targets. This breakthrough could lead to the development of new treatments for bacterial infections without driving resistance.
Researchers have elucidated the molecular composition of a pigment produced by anaerobic bacteria, revealing its role in cellulose degradation. The pigment shows mild antibiotic activity against Gram-positive bacteria.
Biophysicist Christian Spahn's ERC Advanced Grant project aims to capture the ultra-fast intermediate steps of ribosomes in action. Using a supermicroscope, his team will analyze hundreds of thousands of images to visualize rare, short-lived states of ribosomes at atomic resolution.
Scientists have discovered a novel way to block an enzyme involved in regulating blood pressure, called ACE. Ciprofloxacin binds selectively to a different site, blocking angiotensin I but not inhibiting the enzyme's other functions.
Using a novel GPS NMR method, researchers tracked the motion of a key GPCR and found that it doesn't simply switch between two states. Instead, it exists in a dynamic conformational equilibrium between inactive, preactive, and active states.
Researchers discovered an ancient protein that can function in a mirror world, challenging the long-standing assumption that mirror-image proteins cannot bind to nucleic acids. The study found that a simple protein motif is capable of interacting with both natural and mirror-image nucleic acids.
Wesley Sundquist's lab developed lenacapavir, an exceptionally effective HIV-preventing drug with 99.9 to 100 percent efficacy in clinical trials involving tens of thousands of people. The drug has the potential to dramatically decrease infection rates worldwide if distributed broadly.
Researchers at Scripps Research have captured the first detailed images of polymerase theta (Pol-theta) in action, revealing its molecular processes responsible for a range of cancers. The study provides a blueprint for designing more effective cancer drugs by understanding how Pol-theta repairs DNA using a two-step process.
Researchers in the Galej Group at EMBL Grenoble have provided new structural insights into the U11 snRNP subunit of the minor spliceosome, revealing its ability to specifically identify rare substrates. The study sheds light on the complex assembly pathway of the minor spliceosome, which is critical for processing minor introns in genes.
Researchers at the University of Bergen have made a groundbreaking discovery in understanding the structure of protein clumps associated with Huntington's disease. The study provides new insights into the disease's mechanisms and paves the way for the development of diagnostic tools and treatments.
A novel vaccine design has demonstrated robust immune response and broad neutralization of HCV strains in mouse models. The innovative approach employs epitope-focused immunogens, which could pave the way for an effective HCV vaccine, potentially limiting its global spread.
A single mutation in the bovine H5N1 virus can switch its receptor binding from animal-type to human-type receptors, increasing the risk of transmission and potential pandemic. The study highlights the need for continuous surveillance of emerging mutations.
Researchers use cryo-electron microscopy to study Microprocessor's interactions with primary microRNAs. The protein can process multiple pri-miRNAs due to its flexibility and 'tentacle-like' properties.
Georgios Skiniotis joins St. Jude as a faculty member in structural biology, establishing a Center of Excellence for Structural Cell Biology. The center will advance understanding of cell biology from atomic to micron scales using cryo-ET and vEM imaging.
Researchers found that glycans attached to glycosylation enzymes' lectin domains inhibit the enzymes' activity, leading to self-regulation of their own biosynthesis. This unique mechanism sheds light on how glycosylation enzymes choose their substrate proteins in cells.
Researchers at ETH Zurich have discovered a new predatory bacterium, Aureispira, that uses grappling hooks and cannons to capture prey. The bacterium's molecular structures resemble those of pirate tools, allowing it to entangle and kill its victims quickly.
Researchers have made a breakthrough in understanding the rare autoimmune disease anti-NMDAR encephalitis, which can cause psychosis, hallucinations, and blackouts. The study found that different antibodies bind to NMDA receptors in unique ways, suggesting personalized medicine may be key to treating the condition.
Researchers at EMBL Hamburg and CSSB have uncovered the molecular details of vitamin B1 absorption, revealing critical transporters and barriers that hinder its progress. The study sheds light on rare diseases caused by SLC19A3 mutations and potentially life-threatening hidden deficiencies triggered by certain medications.
Scientists have developed MINFLUX microscopy to measure distances within biomolecules, down to one nanometer, and with Ångström precision. This allows for the detection of different conformations of individual proteins and the observation of their interactions.
Researchers at IOCB Prague successfully isolated the proteasome enzyme complex of the T. vaginalis parasite, enabling them to develop new medicines that can target this parasite without harming humans. This breakthrough has critical implications for treating trichomoniasis and reducing HIV risk.
New research from Binghamton University reveals that Mexican jumping bean larvae respond differently to various lighting conditions, with red light stimulating the most vigorous jumps. However, damage to their 'bean' hosts hinders their ability to jump away from stressors.
Gábor Domokos and colleagues develop 'soft cells' with rounded tile shapes that echo those found in nature, including river estuaries, zebra stripes, and muscle tissue. The researchers prove a theorem demonstrating the combinatorial abundance of soft tilings.
Researchers used AlphaFold2 to predict structural effects of mutations on protein stability, finding correlations between small structural changes and stability changes. This breakthrough opens up new possibilities for protein engineering, enabling scientists to design proteins with specific functions more effectively.
Researchers from IOCB Prague uncover the mechanism behind a unique termite defense, where worker termites sacrifice themselves to kill attackers. The discovery sheds light on the enzyme's durability and functionality in harsh conditions.
A new study from the University of California, Davis, reveals how plants break down the hormone strigolactone to become more bushy. The researchers found that enzymes called carboxylesterases play a crucial role in degrading strigolactone, and identified specific amino acids that allow these enzymes to bind to the hormone.
Researchers have identified the critical step in NMDAR's routine where it rotates into an open formation, enabling electrical signals crucial for cognitive functions. This discovery may pave the way for drug compounds that can correct faulty NMDARs, potentially treating conditions like Alzheimer's and depression.
Pamela J. Bjorkman, K. Christopher Garcia, and Ian A. Wilson receive inaugural prize for their groundbreaking research in structural immunology, which has paved the way for novel disease treatments and revealed new insights into the immune system.
Researchers developed a flexible-yet-sturdy morphing structure inspired by the starfish skeleton with 4D morphing features. The structure exhibits self-locking, continuous bending, self-healing, and shape memory features, making it suitable for industry applications in robotics, aviation, and biomedical devices.
Researchers from PSI and ETH Zurich studied connexin-36 gap junction channels and found that antimalarial drug mefloquine binds to the channels, potentially explaining its severe side effects. The study provides new insights into how drugs interact with connexins and may lead to the development of therapies for neurological diseases.
Researchers discovered that enzyme METTL6 interacts with tRNA synthetase to recognize specific tRNAs, enabling precise modification and potential application in cancer treatment. This discovery provides new insights into the molecular machinery of protein production.
A new study developed an AI-based approach, DiffPALM, to predict protein interactions with high accuracy, outperforming traditional methods. This advancement has significant implications for drug development and disease treatment, and the researchers have made it freely available for further research.
Scientists have identified a mechanism that enables enzymes to communicate and produce organic molecules with disease-fighting properties. This breakthrough could aid in the discovery of new drugs by allowing researchers to design or modify enzymes to create novel natural products.
Scientists have identified a new mechanism by which cells counteract a key cancer-promoting protein using an 'invisible' protein called RAI2. In cancer cell lines and patient samples, RAI2 levels are reduced in more severe and treatment-resistant forms of prostate cancer.
Researchers developed tricks to slow down the receptor's closure and speed up freezing process, capturing critical images of kainate receptor in open configurations. These images provide information for drug developers to design more precise medicines for patients.
Four new research papers demonstrate progress in germline-targeting HIV vaccines, which could offer broad protection. The approach involves priming young B cells to produce broadly neutralizing antibodies against HIV, a crucial step towards developing an effective vaccine.
The IRIS beamline at BESSY II has been extended with a nanoscope, enabling the imaging and spectroscopy of structures smaller than a thousandth of a human hair. This upgrade allows researchers to study biological systems, catalysts, polymers, and quantum materials with unprecedented resolution.
A research team has made a significant breakthrough in understanding the GPR156 receptor protein's role in maintaining auditory function. The study reveals that GPR156 exhibits sustained activity even without external stimuli, highlighting its potential as a target for treating congenital hearing impairments.
The study found that crowding and salt enhance the aggregation of alpha-synuclein, while also stabilizing the resulting aggregates. The simulations revealed that certain amino acids exist to prevent aggregation and that proteins orient themselves to minimize interactions between these residues.
Scientists have developed a method to measure pH in cell condensates, a crucial step in understanding their physical and chemical properties. The study reveals that nucleolar proteins exhibit distinct acidic profiles, which create a proton motive force facilitating RNA and protein molecule movement.
TMEM16F, a transmembrane protein, exhibits a wide range of structural conformations that enable its diverse functions. The study reveals unexpected changes in dimerization interface and subunit arrangements, suggesting a dynamic and versatile mechanism for lipid scrambling and ion movement across the cell membrane.
Researchers developed cresomycin, a conformally restricted antibiotic molecule that optimizes for ribosomal binding, inhibiting Gram-negative and positive bacteria, including multi-drug resistant strains. The findings portend favorably for the future discovery of antibacterial agents broadly effective against antimicrobial resistance.
Scientists at UIC and Harvard developed an antibiotic that effectively suppresses pathogenic bacteria resistant to many commonly prescribed antimicrobial drugs. The new antibiotic, cresomycin, binds strongly to ribosomes, disrupting their function and overcoming several common types of drug resistance.
Researchers at ISTA have discovered the composition of poxviral cores, a key factor in their infectivity. The study's findings could lead to the development of new therapeutics targeting the viral core.
Researchers at Duke University have discovered a critical structure on the HIV virus that plays a crucial role in its infection process. By understanding this structure's dynamics, scientists may be able to design broadly neutralizing antibodies for an AIDS vaccine.
Researchers have discovered the atomic structure of an RNA replicase using cryogenic electron microscopy, shedding light on a primordial 'RNA world' that kick-started evolution. The study provides structural insight into an ancient RNA machine thought to reside at the origin of life.
Scientists at the Advanced Science Research Center used X-ray crystallography with elevated temperature and pressure to observe distinct shapes in a protein molecule. The study reveals how proteins change shape to bind metabolites or other proteins, offering insight into disease treatment and development of novel drugs.
Scientists in Germany developed a new analytical method to precisely elucidate the size of particles, structure, and RNA molecules in pharmaceutical products. This information can help evaluate product quality, enabling improved development of new products.
Researchers at Johannes Gutenberg University Mainz discovered a unique cryptochrome protein in marine bristle worms that distinguishes between sunlight and moonlight. The protein's structure reveals an unusual light-induced change from dimer to monomer arrangements, allowing it to synchronize reproduction with lunar phases.
The COVID Moonshot Consortium has discovered novel noncovalent and nonpeptidic inhibitors of the SARS-CoV-2 main protease, with promising bioavailability and antiviral activity. The open-science project has yielded a wealth of data on the virus's main protease, paving the way for future therapeutics.
Researchers at St. Jude Children's Research Hospital have determined the structure of vesicular monoamine transporter 2 (VMAT2), a protein crucial for packaging and releasing neurotransmitters in neurons. The study provides critical information for drug development to treat hyperkinetic disorders like Tourette syndrome.
Scientists have discovered two 'switch' regions in the structure of the K-Ras protein that are affected by dangerous mutations. These regions, located near a protein loop, can amplify cell division and lead to cancer. Researchers say their findings provide new insights into the mechanisms of these mutations and potential drug targets.
Rice University scientists developed a tiny CRISPR-Cas13 system to shred viruses by targeting RNA. The system's unique mechanism and three-dimensional structure were mapped using cryo-electron microscopy, allowing researchers to engineer it for improved precision and specificity.
The team created a proof-of-concept nanocapsule capable of delivering specific payloads to targeted locations, with potential applications in drug delivery, nutrient transport, and other fields. By using calcium metal ions as building blocks, they can generate identical reservoirs for different substances.
AlphaMissense, a machine-learning algorithm, uses structure prediction to classify missense mutations and predict disease-causing genes. The tool has been shown to accurately predict the pathogenicity of 71 million possible single amino acid changes across 19,233 human proteins.
Researchers have discovered how plants pass along chemical markers that instruct cells on using DNA codes, a process known as epigenetic inheritance. The study reveals the role of protein DDM1 in making way for enzymes that add regulatory marks to new DNA strands, preserving genetic controls across generations.
A new technique combining ultrafast physics and spectroscopy reveals the dance of molecular 'coherence' in unprecedented clarity. This shows a vibrational effect, rather than motion for the functional part of the biological reaction that follows.
A team of scientists has successfully elucidated the structure and function of LITE-1, a biomolecule used by Caenorhabditis elegans to detect danger. The researchers used artificial intelligence to predict the structure of LITE-1, which is a channel protein that forms a pore in the cell membrane allowing charged particles to pass through.